ClinVar Miner

Submissions for variant NM_017739.4(POMGNT1):c.794G>C (p.Arg265Pro)

dbSNP: rs386834010
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000674865 SCV000800268 uncertain significance Muscle eye brain disease 2018-05-30 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004702308 SCV005205475 likely pathogenic Autosomal recessive limb-girdle muscular dystrophy 2024-06-25 criteria provided, single submitter clinical testing Variant summary: POMGNT1 c.794G>C (p.Arg265Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251420 control chromosomes. c.794G>C has been reported in the literature in the compound heterozygous or presumed compound heterozygous state in multiple individuals affected with muscle-eye-brain disease (example, Fu_2017, Song_2021), including at least 1 individual carrying a pathogenic variant in trans. These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28765568, 33200426). ClinVar contains an entry for this variant (Variation ID: 558572). Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.